UK-414,495

UK-414,495
Identifiers
CAS Number 337962-93-3 YesY
PubChem (CID) 9949799
ChemSpider 8125410 N
ChEMBL CHEMBL378763 N
Chemical and physical data
Formula C16H25N3O3S
Molar mass 339.453 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

UK-414,495 is a drug developed by Pfizer for the treatment of female sexual arousal disorder.[1] UK-414,495 acts as a potent, selective inhibitor of the enzyme neutral endopeptidase, which normally serves to break down the neuropeptide VIP. The consequent increase in VIP activity alters blood flow to the genital region leading to increased lubrication and muscle relaxation.[2][3][4]

See also

References

  1. 'Female Viagra' will help women increase their sexual arousal. Daily Mail Online 14 April 2010
  2. Armer R, Warne P, Witherington J (2006). "Recent disclosures of clinical drug candidates". Drug News & Perspectives. 19 (1): 65–72. ISSN 0214-0934. PMID 16550257.
  3. Angulo, J. (2010). "Neutral endopeptidase inhibition: could it have a role in the treatment of female sexual arousal disorder?". British Journal of Pharmacology. 160 (1): 48–50. doi:10.1111/j.1476-5381.2010.00693.x. PMC 2860205Freely accessible. PMID 20412067.
  4. Wayman, C.; Baxter, D.; Turner, L.; Van Der Graaf, P.; Naylor, A. (2010). "UK-414,495, a selective inhibitor of neutral endopeptidase, potentiates pelvic nerve-stimulated increases in female genital blood flow in the anaesthetized rabbit". British Journal of Pharmacology. 160 (1): 51–59. doi:10.1111/j.1476-5381.2010.00691.x. PMC 2860206Freely accessible. PMID 20412068.


This article is issued from Wikipedia - version of the 9/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.